Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test Focal Segmental Glomerulosclerosis Gene Panel is 14 days.

What are the prerequisites for the test Focal Segmental Glomerulosclerosis Gene Panel

  • Medical provider must order the test
  • Patient must provide a blood or saliva sample
  • Patient must have a suspected or confirmed diagnosis of Focal Segmental Glomerulosclerosis
  • Patient must have a family history of Focal Segmental Glomerulosclerosis

What are the measure values for the test Focal Segmental Glomerulosclerosis Gene Panel

Gene Measure Value
NPHS1 0-1
NPHS2 0-1
WT1 0-1
TRPC6 0-1

What does this test Focal Segmental Glomerulosclerosis Gene Panel identify?

  • This test identifies mutations in genes associated with Focal Segmental Glomerulosclerosis (FSGS), a rare disease that affects the kidneys.
  • FSGS is a condition where scar tissue develops on the parts of the kidneys that filter waste from the blood.
  • Mutations in certain genes can increase the risk of developing FSGS, and this panel helps to identify those mutations.
  • Early detection of these mutations can help in the diagnosis and management of FSGS, as well as in determining the risk of the disease spreading to other family members.

Why is this test Focal Segmental Glomerulosclerosis Gene Panel taken?

The Focal Segmental Glomerulosclerosis Gene Panel test is taken to diagnose and assess the risk of focal segmental glomerulosclerosis (FSGS). FSGS is a rare disease that affects the kidneys and can lead to kidney failure if left untreated. This genetic test analyzes specific genes associated with FSGS to identify mutations or variations that may increase the risk of developing the disease. By identifying these genetic markers, healthcare providers can provide more personalized treatment and management plans for patients with FSGS.

No FAQs available.

Customer Google Rating